Fulcrum Therapeutics Stock Price History
| FULC Stock | USD 3.85 0.10 2.53% |
Below is the normalized historical share price chart for Fulcrum Therapeutics extending back to July 18, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fulcrum Therapeutics stands at 3.85, as last reported on the 1st of December, with the highest price reaching 3.99 and the lowest price hitting 3.81 during the day.
If you're considering investing in Fulcrum Stock, it is important to understand the factors that can impact its price. Fulcrum Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0604, which denotes the company had a -0.0604% return per unit of risk over the last 3 months. Fulcrum Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fulcrum Therapeutics' Mean Deviation of 4.22, standard deviation of 8.83, and Variance of 77.91 to check the risk estimate we provide.
At present, Fulcrum Therapeutics' Stock Based Compensation To Revenue is projected to increase slightly based on the last few years of reporting. . At present, Fulcrum Therapeutics' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 154.91, whereas Price Earnings Ratio is forecasted to decline to (4.46). Fulcrum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of July 2019 | 200 Day MA 7.0366 | 50 Day MA 3.4314 | Beta 2.235 |
Fulcrum |
Sharpe Ratio = -0.0604
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FULC |
Estimated Market Risk
| 8.94 actual daily | 79 79% of assets are less volatile |
Expected Return
| -0.54 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Fulcrum Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fulcrum Therapeutics by adding Fulcrum Therapeutics to a well-diversified portfolio.
Price Book 0.8071 | Enterprise Value Ebitda (3.09) | Price Sales 2.61 | Shares Float 40.4 M | Wall Street Target Price 5.2857 |
Fulcrum Therapeutics Stock Price History Chart
There are several ways to analyze Fulcrum Stock price data. The simplest method is using a basic Fulcrum candlestick price chart, which shows Fulcrum Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 11, 2024 | 8.85 |
| Lowest Price | November 21, 2024 | 2.97 |
Fulcrum Therapeutics December 1, 2024 Stock Price Synopsis
Various analyses of Fulcrum Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Fulcrum Stock. It can be used to describe the percentage change in the price of Fulcrum Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Fulcrum Stock.| Fulcrum Therapeutics Price Rate Of Daily Change | 0.97 | |
| Fulcrum Therapeutics Price Action Indicator | (0.10) | |
| Fulcrum Therapeutics Price Daily Balance Of Power | (0.56) |
Fulcrum Therapeutics December 1, 2024 Stock Price Analysis
Fulcrum Stock Price History Data
The price series of Fulcrum Therapeutics for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 5.9 with a coefficient of variation of 44.52. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.2. The median price for the last 90 days is 3.49.| Open | High | Low | Close | Volume | ||
12/01/2024 | 3.93 | 3.99 | 3.81 | 3.85 | ||
| 11/29/2024 | 3.93 | 3.99 | 3.81 | 3.85 | 527,111 | |
| 11/27/2024 | 3.57 | 4.08 | 3.57 | 3.95 | 1,008,852 | |
| 11/26/2024 | 3.46 | 3.62 | 3.31 | 3.55 | 848,008 | |
| 11/25/2024 | 3.33 | 3.56 | 3.24 | 3.44 | 957,857 | |
| 11/22/2024 | 2.98 | 3.30 | 2.95 | 3.25 | 812,159 | |
| 11/21/2024 | 3.02 | 3.08 | 2.96 | 2.97 | 460,986 | |
| 11/20/2024 | 2.98 | 3.06 | 2.96 | 2.99 | 782,466 | |
| 11/19/2024 | 3.03 | 3.03 | 2.86 | 3.01 | 725,621 | |
| 11/18/2024 | 3.01 | 3.10 | 2.93 | 3.03 | 2,355,192 | |
| 11/15/2024 | 3.30 | 3.30 | 2.95 | 3.01 | 1,275,437 | |
| 11/14/2024 | 3.57 | 3.57 | 3.28 | 3.32 | 654,327 | |
| 11/13/2024 | 3.94 | 3.94 | 3.52 | 3.56 | 870,143 | |
| 11/12/2024 | 3.72 | 3.82 | 3.54 | 3.64 | 874,674 | |
| 11/11/2024 | 3.52 | 3.72 | 3.52 | 3.64 | 657,359 | |
| 11/08/2024 | 3.50 | 3.53 | 3.38 | 3.49 | 502,218 | |
| 11/07/2024 | 3.43 | 3.63 | 3.42 | 3.48 | 1,159,717 | |
| 11/06/2024 | 3.43 | 3.48 | 3.25 | 3.43 | 1,583,167 | |
| 11/05/2024 | 3.28 | 3.35 | 3.21 | 3.32 | 989,213 | |
| 11/04/2024 | 3.20 | 3.38 | 3.13 | 3.26 | 843,623 | |
| 11/01/2024 | 3.17 | 3.22 | 3.14 | 3.21 | 420,759 | |
| 10/31/2024 | 3.25 | 3.28 | 3.13 | 3.16 | 433,685 | |
| 10/30/2024 | 3.21 | 3.30 | 3.18 | 3.24 | 430,896 | |
| 10/29/2024 | 3.24 | 3.31 | 3.20 | 3.24 | 340,487 | |
| 10/28/2024 | 3.24 | 3.30 | 3.21 | 3.24 | 696,064 | |
| 10/25/2024 | 3.23 | 3.30 | 3.17 | 3.19 | 509,622 | |
| 10/24/2024 | 3.24 | 3.33 | 3.21 | 3.24 | 361,549 | |
| 10/23/2024 | 3.40 | 3.46 | 3.18 | 3.25 | 902,162 | |
| 10/22/2024 | 3.49 | 3.56 | 3.36 | 3.39 | 541,473 | |
| 10/21/2024 | 3.52 | 3.59 | 3.48 | 3.51 | 503,663 | |
| 10/18/2024 | 3.54 | 3.67 | 3.44 | 3.51 | 719,290 | |
| 10/17/2024 | 3.60 | 3.70 | 3.44 | 3.55 | 656,267 | |
| 10/16/2024 | 3.69 | 3.75 | 3.53 | 3.62 | 1,066,446 | |
| 10/15/2024 | 3.58 | 3.71 | 3.49 | 3.66 | 493,734 | |
| 10/14/2024 | 3.46 | 3.58 | 3.45 | 3.57 | 424,128 | |
| 10/11/2024 | 3.28 | 3.50 | 3.26 | 3.48 | 651,483 | |
| 10/10/2024 | 3.39 | 3.44 | 3.18 | 3.27 | 685,689 | |
| 10/09/2024 | 3.53 | 3.54 | 3.36 | 3.41 | 542,608 | |
| 10/08/2024 | 3.60 | 3.63 | 3.51 | 3.54 | 640,740 | |
| 10/07/2024 | 3.78 | 3.78 | 3.55 | 3.57 | 699,483 | |
| 10/04/2024 | 3.72 | 3.84 | 3.69 | 3.82 | 704,007 | |
| 10/03/2024 | 3.82 | 3.88 | 3.63 | 3.67 | 732,128 | |
| 10/02/2024 | 3.60 | 3.92 | 3.55 | 3.87 | 1,076,584 | |
| 10/01/2024 | 3.58 | 3.72 | 3.53 | 3.60 | 854,423 | |
| 09/30/2024 | 3.75 | 3.83 | 3.57 | 3.57 | 879,280 | |
| 09/27/2024 | 4.06 | 4.23 | 3.77 | 3.77 | 1,882,885 | |
| 09/26/2024 | 3.52 | 4.75 | 3.52 | 4.00 | 7,637,139 | |
| 09/25/2024 | 3.21 | 3.50 | 3.10 | 3.47 | 1,869,554 | |
| 09/24/2024 | 3.19 | 3.25 | 3.10 | 3.21 | 993,464 | |
| 09/23/2024 | 3.40 | 3.42 | 3.17 | 3.20 | 1,087,738 | |
| 09/20/2024 | 3.41 | 3.44 | 3.31 | 3.36 | 1,956,654 | |
| 09/19/2024 | 3.48 | 3.61 | 3.43 | 3.45 | 1,097,189 | |
| 09/18/2024 | 3.45 | 3.55 | 3.34 | 3.44 | 1,473,731 | |
| 09/17/2024 | 3.23 | 3.81 | 3.18 | 3.49 | 4,465,796 | |
| 09/16/2024 | 3.17 | 3.40 | 3.12 | 3.18 | 2,922,930 | |
| 09/13/2024 | 3.44 | 3.50 | 3.00 | 3.18 | 7,662,139 | |
| 09/12/2024 | 2.94 | 3.69 | 2.87 | 3.44 | 34,271,504 | |
| 09/11/2024 | 8.37 | 8.87 | 8.30 | 8.85 | 716,511 | |
| 09/10/2024 | 8.64 | 8.84 | 8.35 | 8.43 | 514,809 | |
| 09/09/2024 | 8.90 | 9.30 | 8.50 | 8.63 | 994,217 | |
| 09/06/2024 | 8.68 | 8.76 | 8.37 | 8.54 | 575,774 |
About Fulcrum Therapeutics Stock history
Fulcrum Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fulcrum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fulcrum Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fulcrum Therapeutics stock prices may prove useful in developing a viable investing in Fulcrum Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 61.3 M | 32.4 M | |
| Net Loss | -98.9 M | -103.8 M |
Fulcrum Therapeutics Quarterly Net Working Capital |
|
Fulcrum Therapeutics Stock Technical Analysis
Fulcrum Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Fulcrum Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fulcrum Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Fulcrum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fulcrum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (2.14) | |||
| Treynor Ratio | (0.79) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Fulcrum Stock analysis
When running Fulcrum Therapeutics' price analysis, check to measure Fulcrum Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulcrum Therapeutics is operating at the current time. Most of Fulcrum Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fulcrum Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulcrum Therapeutics' price. Additionally, you may evaluate how the addition of Fulcrum Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |